Using technology based upon genetic suppressor elements (GSEs), which the applicant has played a large role in developing, Dr. Gudkov wishes to identify cellular factors affecting either expression or function of the p53 tumor suppressor gene. Regulation of transcription of p53 has not received a lot of scientific scrutiny since elevated levels of p53 protein- associated with its growth inhibitory and apoptotic roles is primarily due to conformational changes leading to an increased stability. Using a p53 responsive promoter-Lac Z reporter construct in transgenic mice Dr. Gudkov has shown tissue and developmental stage-specific expression of the Lac Z reporter. This expression correlates directly with p53 mRNA expression. He has further demonstrated that widespread apoptosis in early embryos following DNA damage is correlated directly with p53 mRNA expression and its translation. The applicant intends to determine the regulation of this mRNA expression. Various parameters will be investigated, including the possibility of positive and negative transcriptional factors and mRNA stability. cDNA expression libraries (full length cDNAs and GSEs) with be used to screen for clones affecting p53 mRNA expression. Using the GSE strategy that was used successfully to identify a growth suppressor, p33(ING1), the applicant will screen for clones that induce phenotypes associated with p53 inactivation. In this case GSEs are isolated from retroviral libraries of randomly fragmented cDNA sequences identified through two-hybrid interaction trap procedures using p53 and p33(ING1) proteins as baits. The third major aim will be to attempt to place the position and role of these candidate proteins in the p53 pathway, via overexpression and suppression studies. The expression patterns of the candidate proteins and their chromosome map positions are included in these aims.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Illinois at Chicago
Schools of Medicine
United States
Zip Code
Gasparian, Alexander V; Burkhart, Catherine A; Purmal, Andrei A et al. (2011) Curaxins: anticancer compounds that simultaneously suppress NF-?B and activate p53 by targeting FACT. Sci Transl Med 3:95ra74
Gudkov, Andrei V; Gurova, Katerina V; Komarova, Elena A (2011) Inflammation and p53: A Tale of Two Stresses. Genes Cancer 2:503-16
Neznanov, Nickolay; Komarov, Andrei P; Neznanova, Lubov et al. (2011) Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib. Oncotarget 2:209-21
Hu, Yan; Spengler, Mary L; Kuropatwinski, Karen K et al. (2011) Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein, BMAL1. Oncotarget 2:1279-90
Leonova, Katerina I; Shneyder, Jelena; Antoch, Marina P et al. (2010) A small molecule inhibitor of p53 stimulates amplification of hematopoietic stem cells but does not promote tumor development in mice. Cell Cycle 9:1434-43
Gudkov, Andrei V; Komarova, Elena A (2010) Radioprotection: smart games with death. J Clin Invest 120:2270-3
Demidenko, Zoya N; Korotchkina, Lioubov G; Gudkov, Andrei V et al. (2010) Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci U S A 107:9660-4
Gasparian, Alexander V; Neznanov, Nickolay; Jha, Sujata et al. (2010) Inhibition of encephalomyocarditis virus and poliovirus replication by quinacrine: implications for the design and discovery of novel antiviral drugs. J Virol 84:9390-7
Gudkov, Andrei V; Komarova, Elena A (2010) Pathologies associated with the p53 response. Cold Spring Harb Perspect Biol 2:a001180
Kelly, Ryan M; Goren, Emily M; Taylor, Patricia A et al. (2010) Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation. Blood 115:1088-97

Showing the most recent 10 out of 49 publications